TIRF high-content assay development for the evaluation of drug efficacy of chemotherapeutic agents against EGFR-/HER2-positive breast cancer cell lines

Analytical and Bioanalytical Chemistry
Jieun KiJoon Myong Song

Abstract

Elevated expression of epidermal growth factor receptor (EGFR) is reported to be associated with poor prognosis in breast cancer. EGFR subtype identification plays a crucial role in deciding the drug combination to treat the cancer patients. Conventional application of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) produces more discordance results in EGFR subtype identification of cancer specimens. The present study is designed to develop an analytical method for simultaneous identification of cell surface biomarkers and quantitative estimation of drug efficacy in cancer specimens. For this study, we have utilized a total internal reflection fluorescence microscope (TIRFM), Qdot molecular probes and chemotherapeutic agent camptothecin (CPT)-treated breast cancer cell lines namely MCF-7, SK-BR-3 and JIMT-1. Highly sensitive detection signals with low background noise generated from the evanescent field excitation of TIRFM make it a highly suitable tool to detect the cell surface biomarkers in living cells. Moreover, single wavelength excitation of Qdot probes offers multicolour imaging with strong emission brightness. In the present study, TIRF high-content imaging system simultaneously showed the expr...Continue Reading

References

Dec 8, 1998·The Biochemical Journal·W El-AssaadG S Dbaibo
Jul 8, 2003·The Journal of Pathology·Caroline J WittonJohn M S Bartlett
May 5, 2004·Proceedings of the National Academy of Sciences of the United States of America·Marina FixSanford M Simon
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezRobert B Jenkins
Sep 15, 2006·Analytical Chemistry·Michael S Wilson, Weiyan Nie
Mar 23, 2007·Analytical and Bioanalytical Chemistry·Seong Ho KangEdward S Yeung
Apr 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitch DowsettBrian Leyland-Jones
Jun 25, 2009·Nature Reviews. Cancer·Thomas G Cotter
Mar 18, 2011·Nature·Marcus E Peter
Mar 10, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Lanhai LüJie Xu
Jan 1, 2011·Annual Review of Chemical and Biomolecular Engineering·Eric T Boder, Wei Jiang
Mar 16, 2013·Analytical and Bioanalytical Chemistry·Anna N BerlinaBoris B Dzantiev
Apr 29, 2014·The Analyst·T R PisanicT H Wang
Apr 19, 2015·Breast Cancer Research : BCR·Paolo NuciforoMaurizio Scaltriti
Jun 17, 2015·Annual Review of Analytical Chemistry·Joachim Wegener
Aug 27, 2015·PloS One·Kyle L EllefsenIan Parker

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.